Mind Pharmaceuticals
Mind Pharmaceuticals Corp
Mind Pharmaceuticals is a Clinical Asset Stage Company located in New Haven, CT, dedicated to addressing significant unmet needs in the Central Nervous System (CNS) domain. The company's primary focus is on developing innovative treatments for Treatment Resistant Depression and Headache Disorders, responding to serious gaps in current mental health therapies.
Products & Team
MIND001
MIND001 is an intravenous formulation of N,N-Dimethyltryptamine (DMT), a naturally occurring psychedelic compound. It targets receptors in the brain to potentially offer new therapeutic options for patients with Treatment Resistant Depression.
MIND001 addresses the urgent need for effective treatments for patients suffering from Treatment Resistant Depression, who have not seen improvement with standard therapies.
Customers face persistent mental health challenges, with inadequate treatment options leading to significant life disruptions and poor quality of life.